Neil S Horowitz

Summary

Affiliation: Washington University School of Medicine
Country: USA

Publications

  1. ncbi request reprint Adjuvant high dose rate vaginal brachytherapy as treatment of stage I and II endometrial carcinoma
    Neil S Horowitz
    The Swedish Medical Center, Seattle, Washington, USA
    Obstet Gynecol 99:235-40. 2002
  2. ncbi request reprint The significance of pneumatosis intestinalis or bowel perforation in patients with gynecologic malignancies
    Neil S Horowitz
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Gynecol Oncol 86:79-84. 2002
  3. doi request reprint Prognostic determinants in patients with uterine and ovarian clear carcinoma
    J Alejandro Rauh-Hain
    Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
    Gynecol Oncol 125:376-80. 2012
  4. ncbi request reprint Prognostic determinants in patients with uterine and ovarian carcinosarcoma
    J Alejandro Rauh-Hain
    Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Yawkey 9E, Boston, MA 02114, USA
    J Reprod Med 58:297-304. 2013
  5. doi request reprint Changes in serum CA-125 can predict optimal cytoreduction to no gross residual disease in patients with advanced stage ovarian cancer treated with neoadjuvant chemotherapy
    Noah Rodriguez
    Brigham and Women s Hospital, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Harvard Medical School, Boston, MA, USA
    Gynecol Oncol 125:362-6. 2012
  6. ncbi request reprint CA-125 response in patients with recurrent ovarian or primary peritoneal cancer treated with pegylated liposomal doxorubicin or topotecan
    Gabrielle Gossner
    Washington University School of Medicine, St Louis, MO 63110, USA
    Gynecol Oncol 103:212-8. 2006
  7. doi request reprint Patterns of recurrence in patients treated with bevacizumab in the primary treatment of advanced epithelial ovarian cancer
    Jose Alejandro Rauh-Hain
    Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA 02114, USA
    Int J Gynecol Cancer 23:1219-25. 2013
  8. ncbi request reprint Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: a SEER analysis
    Roberto Vargas
    Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA Division of Gynecologic Oncology, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    Gynecol Oncol 133:216-20. 2014
  9. doi request reprint Upper abdominal procedures in advanced stage ovarian or primary peritoneal carcinoma patients with minimal or no gross residual disease: an analysis of Gynecologic Oncology Group (GOG) 182
    Noah Rodriguez
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    Gynecol Oncol 130:487-92. 2013
  10. doi request reprint Prognostic determinants in patients with stage I uterine papillary serous carcinoma: a 15-year multi-institutional review
    Whitfield B Growdon
    Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA 02114, USA
    Int J Gynecol Cancer 22:417-24. 2012

Collaborators

Detail Information

Publications34

  1. ncbi request reprint Adjuvant high dose rate vaginal brachytherapy as treatment of stage I and II endometrial carcinoma
    Neil S Horowitz
    The Swedish Medical Center, Seattle, Washington, USA
    Obstet Gynecol 99:235-40. 2002
    ..To evaluate the efficacy of high dose rate vaginal brachytherapy in the treatment of International Federation of Gynecology and Obstetrics stage IB, IC, and II endometrial carcinoma after surgical staging and complete lymphadenectomy...
  2. ncbi request reprint The significance of pneumatosis intestinalis or bowel perforation in patients with gynecologic malignancies
    Neil S Horowitz
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Gynecol Oncol 86:79-84. 2002
    ..The objectives of this study were to evaluate the clinical significance and outcome of pneumatosis intestinalis or bowel perforation in patients with gynecologic malignancies...
  3. doi request reprint Prognostic determinants in patients with uterine and ovarian clear carcinoma
    J Alejandro Rauh-Hain
    Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
    Gynecol Oncol 125:376-80. 2012
    ..The purpose of this study is to analyze and compare the demographics, treatment, recurrence, and survival rates in patients with uterine clear cell carcinoma (UCCC) and ovarian clear cell carcinoma (OCCC)...
  4. ncbi request reprint Prognostic determinants in patients with uterine and ovarian carcinosarcoma
    J Alejandro Rauh-Hain
    Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Yawkey 9E, Boston, MA 02114, USA
    J Reprod Med 58:297-304. 2013
    ..To analyze and compare the demographics, treatment, recurrence, and survival rates in patients with carcinosarcoma of the uterus and ovary...
  5. doi request reprint Changes in serum CA-125 can predict optimal cytoreduction to no gross residual disease in patients with advanced stage ovarian cancer treated with neoadjuvant chemotherapy
    Noah Rodriguez
    Brigham and Women s Hospital, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Harvard Medical School, Boston, MA, USA
    Gynecol Oncol 125:362-6. 2012
    ..To evaluate the predictive power of serum CA-125 changes in the management of patients undergoing neoadjuvant chemotherapy followed by interval debulking surgery (NACT-IDS) for a new diagnosis of epithelial ovarian carcinoma (EOC)...
  6. ncbi request reprint CA-125 response in patients with recurrent ovarian or primary peritoneal cancer treated with pegylated liposomal doxorubicin or topotecan
    Gabrielle Gossner
    Washington University School of Medicine, St Louis, MO 63110, USA
    Gynecol Oncol 103:212-8. 2006
    ..In this study, we sought to gain insight into response patterns regarding CA-125 in responders vs. non-responders and to determine whether specific "cut-off" values could help predict ultimate clinical response...
  7. doi request reprint Patterns of recurrence in patients treated with bevacizumab in the primary treatment of advanced epithelial ovarian cancer
    Jose Alejandro Rauh-Hain
    Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA 02114, USA
    Int J Gynecol Cancer 23:1219-25. 2013
    ....
  8. ncbi request reprint Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: a SEER analysis
    Roberto Vargas
    Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA Division of Gynecologic Oncology, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    Gynecol Oncol 133:216-20. 2014
    ..The objective of this investigation was to evaluate the risk of nodal metastasis in patients with endometrial cancer, using the Mayo criteria, in a population-based analysis...
  9. doi request reprint Upper abdominal procedures in advanced stage ovarian or primary peritoneal carcinoma patients with minimal or no gross residual disease: an analysis of Gynecologic Oncology Group (GOG) 182
    Noah Rodriguez
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    Gynecol Oncol 130:487-92. 2013
    ....
  10. doi request reprint Prognostic determinants in patients with stage I uterine papillary serous carcinoma: a 15-year multi-institutional review
    Whitfield B Growdon
    Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA 02114, USA
    Int J Gynecol Cancer 22:417-24. 2012
    ..The aim of this retrospective, multi-institutional study was to evaluate the importance of surgical staging for stage I uterine papillary serous carcinomas (UPSCs) to determine optimal management of this rare tumor...
  11. doi request reprint Primary debulking surgery versus neoadjuvant chemotherapy in stage IV ovarian cancer
    J Alejandro Rauh-Hain
    Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
    Ann Surg Oncol 19:959-65. 2012
    ..We hypothesized that stage IV ovarian cancer patients would likely benefit from NACT-IDS by achieving similar outcomes with less morbidity...
  12. doi request reprint Carcinosarcoma of the ovary: a case-control study
    J Alejandro Rauh-Hain
    Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA 02114, USA
    Gynecol Oncol 121:477-81. 2011
    ..The purpose of this study is to compare response to chemotherapy and survival in patients with advanced stage carcinosarcoma of the ovary...
  13. doi request reprint Platinum resistance after neoadjuvant chemotherapy compared to primary surgery in patients with advanced epithelial ovarian carcinoma
    J Alejandro Rauh-Hain
    Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
    Gynecol Oncol 129:63-8. 2013
    ..It remains unresolved whether NACT-IDS increases the risk of platinum resistance. We compared response to chemotherapy in patients that received NACT-IDS vs. PDS...
  14. ncbi request reprint Adequate staging for uterine cancer can be performed through Pfannenstiel incisions
    Neil S Horowitz
    Washington University School of Medicine, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, St Louis, MO, USA
    Gynecol Oncol 88:404-10. 2003
    ..To determine if the type of operative incision influences the adequacy of surgical staging in patients with uterine cancer...
  15. doi request reprint Does neoadjuvant chemotherapy decrease the risk of hospital readmission following debulking surgery?
    Michael J Worley
    Division of Gynecologic Oncology, Brigham and Women s Hospital, Boston, MA, USA
    Gynecol Oncol 129:69-73. 2013
    ..To compare primary debulking surgery (PDS) vs. neoadjuvant chemotherapy with interval debulking surgery (NACT-IDS) among elderly patients with ovarian/fallopian tube/primary peritoneal carcinoma...
  16. ncbi request reprint Patterns of recurrence in advanced epithelial ovarian, fallopian tube and peritoneal cancers treated with intraperitoneal chemotherapy
    Katharine M Esselen
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women s Hospital, Boston, MA 02215, USA
    Gynecol Oncol 127:51-4. 2012
    ..To examine the distribution and outcomes of recurrent disease in patients with ovarian, fallopian tube and peritoneal cancers after optimal cytoreduction and adjuvant intraperitoneal (IP) chemotherapy...
  17. doi request reprint Should stage IIIC ovarian cancer be further stratified by intraperitoneal vs. retroperitoneal only disease?: a Gynecologic Oncology Group study
    Bunja Rungruang
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Magee Womens Hospital of UPMC, Pittsburgh, PA, USA
    Gynecol Oncol 124:53-8. 2012
    ..To examine whether clinical outcomes varied with intraperitoneal (IP) and/or retroperitoneal (RP) involvement in stage IIIC epithelial ovarian cancer (EOC) patients with microscopic residual disease after cytoreduction...
  18. ncbi request reprint Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer
    Neil S Horowitz
    Division of Gynecologic Oncology, Departments of Obstetrics and Gynecology, Washington University School of Medicine, St Louis, MO 63110, USA
    Gynecol Oncol 95:546-51. 2004
    ....
  19. ncbi request reprint Should the presence of lymphvascular space involvement be used to assign patients to adjuvant therapy following hysterectomy for unstaged endometrial cancer?
    David E Cohn
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Arthur G James Cancer Hospital and Solove Research Institute, The Ohio State University College of Medicine, Columbus, Ohio 43210, USA
    Gynecol Oncol 87:243-6. 2002
    ..As such, the presence of LVSI may indicate the need for lymphadenectomy or adjuvant therapy for potential regional lymph node metastases in patients with unstaged endometrial cancer...
  20. doi request reprint Comparison of clinical outcomes of patients with clear cell and endometrioid ovarian cancer associated with endometriosis to papillary serous carcinoma of the ovary
    Michelle Davis
    Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA Division of Gynecologic Oncology, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    Gynecol Oncol 132:760-6. 2014
    ..The aim of this investigation was to compare outcomes of patients with clear cell carcinoma (CCC) and endometrioid carcinoma (EC) of the ovary associated with endometriosis to patients with ovarian papillary serous carcinoma (PSC)...
  21. doi request reprint ACR Appropriateness Criteria® pretreatment planning of invasive cancer of the cervix
    Cary Lynn Siegel
    Mallinckrodt Institute of Radiology, St Louis, Missouri, USA
    J Am Coll Radiol 9:395-402. 2012
    ..In those instances in which evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment...
  22. doi request reprint Prognostic determinants in patients with stage IIIC and IV uterine papillary serous carcinoma
    J Alejandro Rauh-Hain
    Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
    Gynecol Oncol 119:299-304. 2010
    ..The aim of this study was to evaluate the survival impact of cytoreductive surgery and other prognostic determinants in patients with stage IIIC and IV uterine papillary serous carcinoma (UPSC)...
  23. ncbi request reprint Utility and cost-effectiveness of preoperative autologous blood donation in gynecologic and gynecologic oncology patients
    Neil S Horowitz
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Washington University Medical Center, St Louis, Missouri, USA
    Obstet Gynecol 99:771-6. 2002
    ..To evaluate utility and cost-effectiveness of preoperative autologous blood donation in gynecologic and gynecologic oncology patients...
  24. ncbi request reprint The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model
    Neil S Horowitz
    Department of Obstetrics and Gynecology, Washington University School of Medicine, St Louis, MO 63110, USA
    Gynecol Oncol 94:67-73. 2004
    ....
  25. ncbi request reprint Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinoma
    Ami P Vaidya
    Division of Gynecologic Oncology, Gillette Center for Women s Cancers, Massachusetts General Hospital, Boston, MA 02114, USA
    Gynecol Oncol 103:684-7. 2006
    ..The current study was undertaken to compare outcomes, stage for stage, of uterine MMMT with poor prognosis endometrial adenocarcinomas...
  26. ncbi request reprint Primary peritoneal carcinoma presenting as adenocarcinoma on a Pap smear. A case report
    Jason D Wright
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University School of Medicine, St Louis, Missouri, USA
    J Reprod Med 47:933-5. 2002
    ..Primary peritoneal carcinoma is an uncommon malignancy that usually presents with gastrointestinal symptoms from abdominal carcinomatosis...
  27. doi request reprint ACR appropriateness Criteria® pretreatment evaluation and follow-up of endometrial cancer of the uterus
    Jean Hwa Lee
    Department of Radiology, University of Washington School of Medicine, Seattle, WA, USA
    Ultrasound Q 27:139-45. 2011
    ..Literature on the indications and usefulness of these imaging studies for endometrial cancer is reviewed...
  28. ncbi request reprint Placental site trophoblastic tumor presenting with a pneumothorax during pregnancy
    Jason D Wright
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Obstet Gynecol 100:1141-4. 2002
    ..Placental site trophoblastic tumor is a rare form of gestational trophoblastic disease that commonly presents with vaginal bleeding and amenorrhea after pregnancy...
  29. doi request reprint Management of gestational trophoblastic neoplasia
    Neil S Horowitz
    New England Trophoblastic Disease Center, Brigham and Women s Hospital, Department of Obstetrics and Gynecology, Boston, MA 02115, USA
    Semin Oncol 36:181-9. 2009
    ..Although GTN typically follows a molar pregnancy, they can occur after any gestational event. This review discusses the basic principles of management and recent advances in the diagnosis and treatment of patients with GTN...
  30. ncbi request reprint Case records of the Massachusetts General Hospital. Case 11-2006. A 54-year-old woman with a mass in the pelvis
    Carolyn N Krasner
    Gillette Center for Women s Cancers, Massachusetts General Hospital, USA
    N Engl J Med 354:1615-25. 2006
  31. ncbi request reprint Advances in the surgical management of ovarian cancer
    Neil S Horowitz
    Department Gynecologic Oncology, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    J Reprod Med 50:454-66. 2005
    ..Further work needs to be undertaken in screening, prevention, surgery and adjuvant therapy...
  32. ncbi request reprint PET-CT vs. CT alone in ovarian cancer recurrence
    Sunit Sebastian
    Department of Radiology, Massachusetts General Hospital, 55 Fruit Street, White 270, Boston, MA 02114, USA
    Abdom Imaging 33:112-8. 2008
    ..To compare fusion, positron emission tomography-computed tomography (PET-CT) with CT alone in detecting ovarian carcinoma recurrence...
  33. ncbi request reprint Profiling microdissected epithelium and stroma to model genomic signatures for cervical carcinogenesis accommodating for covariates
    David Gius
    Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland 20892, USA
    Cancer Res 67:7113-23. 2007
    ....
  34. ncbi request reprint Evaluating adnexal lesions: which need follow-up?
    Janet C Miller
    Department of Radiology, Massachusetts General Hospital, Boston, Mass, USA
    J Am Coll Radiol 4:725-9. 2007